Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Regeneron Pharmaceutical (REGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 54,987,008
  • Shares Outstanding, K 106,290
  • Annual Sales, $ 4,860 M
  • Annual Income, $ 895,520 K
  • 36-Month Beta 1.53
  • Price/Sales 11.51
  • Price/Cash Flow 52.42
  • Price/Book 11.50

Price Performance

See More
Period Period Low Period High Performance
1-Month
448.08 +14.52%
on 05/30/17
543.55 -5.60%
on 06/22/17
+57.95 (+12.73%)
since 05/26/17
3-Month
360.00 +42.53%
on 04/27/17
543.55 -5.60%
on 06/22/17
+140.12 (+37.57%)
since 03/24/17
52-Week
325.35 +57.71%
on 11/04/16
543.55 -5.60%
on 06/22/17
+173.64 (+51.15%)
since 06/24/16

Most Recent Stories

More News
Novartis Cardiovascular Drug Positive, NSCLC Drug Approved

Shares of Novartis AG (NVS) were up after the company announced positive top-line results from the global phase III study, CANTOSon cardiovascular drug.

LLY : 84.06 (+0.20%)
NVS : 85.94 (-0.46%)
REGN : 513.99 (-0.65%)
GSK : 44.20 (-0.20%)
Sonic, Forestar post gains; BlackBerry, Regeneron fall

NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday:

RRC : 23.22 (+4.31%)
SONC : 27.65 (-1.29%)
BBBY : 29.55 (-0.34%)
FOR : 17.65 (+0.28%)
SNX : 127.82 (-0.43%)
REGN : 513.99 (-0.65%)
SNCR : 16.19 (-0.31%)
Kamada Withdraws Inhaled AAT Marketing Application in EU

Kamada Ltd.'s (KMDA) decided to withdraw the marketing authorization application (MAA) for its inhaled formulation of Alpha-1 Antitrypsin (AAT) in the EU.

BAYRY : 136.8000 (+0.32%)
SHPG : 174.02 (+0.60%)
REGN : 513.99 (-0.65%)
KMDA : 6.05 (+0.83%)
Here's Why Investors Are Glued to Vertex Pharma (VRTX) Stock

Vertex Pharmaceuticals, Inc. (VRTX), has been attracting investor attention.

CNCE : 14.75 (+1.51%)
VVUS : 1.21 (-0.82%)
VRTX : 132.94 (-0.42%)
REGN : 513.99 (-0.65%)
Regeneron (REGN) Stock on Fire: What's Behind the Surge?

Shares of Regeneron Pharmaceuticals, Inc. (REGN) have moved up 14.8% over the last 30 days.

VVUS : 1.21 (-0.82%)
NVS : 85.94 (-0.46%)
REGN : 513.99 (-0.65%)
SNY : 49.63 (+0.61%)
Here's Why Geron (GERN) is a Good Stock to Invest in Now

Geron Corporation (GERN) is developing anti-cancer therapies based on telomerase inhibitors.

VVUS : 1.21 (-0.82%)
JNJ : 136.49 (+0.04%)
GERN : 2.94 (unch)
REGN : 513.99 (-0.65%)
BioDelivery Inks New Contract with CVS/Caremark, Shares Up

BioDelivery Sciences International, Inc. (BDSI) announced an agreement with CVS/Caremark to extend access to its pain management product Belbuca and opioid dependence product Bunavail through 2020.

CVS : 80.05 (+3.41%)
ENDP : 11.93 (+0.76%)
BDSI : 2.92 (-1.02%)
REGN : 513.99 (-0.65%)
Indivor's Opioid Use Disorder Drug Meets Primary Endpoint

Indivior PLC (INVVY) announced that a pivotal study (RB-US-13-0001) evaluating its candidate, RBP-6000, in patients with moderate-to-severe opioid use disorder (OUD) met its primary endpoint.

VVUS : 1.21 (-0.82%)
MEIP : 2.27 (-1.30%)
REGN : 513.99 (-0.65%)
INVVY : 21.2460 (-1.41%)
Regeneron Details Royalty Agreement with Novartis for Canakinumab (ACZ885)

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today provided details of the royalty it receives on any sales of canakinumab (ACZ885), an anti-IL1B antibody. Under a 2009 agreement with Novartis, Regeneron...

REGN : 513.99 (-0.65%)
AveXis (AVXS) Jumps: Stock Rises 7.1%

AveXis, Inc.(AVXS) was a big mover last session, as the company saw its shares rise over 7% on the day.

REGN : 513.99 (-0.65%)
AVXS : 79.38 (+1.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM....

See More

Support & Resistance

2nd Resistance Point 531.81
1st Resistance Point 524.57
Last Price 513.99
1st Support Level 505.17
2nd Support Level 493.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.